Hospital for Special Surgery - Archive (Spiera)

2019
March
20,
2019
| 01:00 PM America/New_York
Hospital for Special Surgery is evaluating a novel therapeutic approach for diffuse cutaneous systemic sclerosis (dcSSc), one of the most serious, potentially disabling and life-threatening rheumatic diseases. The double-blind, randomized, placebo-co...
Read more
2018
November
19,
2018
| 01:00 PM America/New_York
Robert F. Spiera, MD, rheumatologist at HSS, is interviewed at the annual ACR conference by MedPage Today talking about the study that he presented on the safety and efficacy of lenabasum in diffuse scleroderma patients. He explains how his team saw...
Read more
August
08,
2018
| 01:00 PM America/New_York
The Rheumatologist published a feature article on rheumatologists whose children followed in their footsteps to practice medicine and interviewed HSS rheumatologist Robert F. Spiera, MD, who was influenced by his father Harry Spiera, MD, to become a ...
Read more
Tags
June
21,
2018
| 01:00 PM America/New_York
Scleroderma News reported on a study that found that lenabasum, a potential treatment of diffuse cutaneous scleroderma, was shown to be safe and beneficial for patients during a Phase 2 clinical trial. HSS rheumatologist Robert F. Spiera, MD, the tr...
Read more
Tags
May
18,
2018
| 01:00 PM America/New_York
Rheumatology Advisor interviewed HSS rheumatologist Robert F. Spiera, MD, about risk factors and treatment strategies for pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc). "PAH is an important complication of SSc, and ...
Read more
Tags
May
17,
2018
| 01:00 PM America/New_York
Scleroderma News highlighted a study that found that lenabasum, a potential treatment of diffuse cutaneous scleroderma, was shown to be safe, well-tolerated and beneficial for patients. HSS rheumatologist Robert F. Spiera, MD, the trial's principal ...
Read more
Tags
January
03,
2018
| 01:00 PM America/New_York
Medscape interviewed HSS rheumatologists Robert F. Spiera, MD and Susan M. Goodman, MD about their research presented at the 2017 American College of Rheumatology (ACR) Annual Meeting. Dr. Goodman gave several presentations about social factors, suc...
Read more